Onconetix (ONCO) Other Operating Expenses (2022 - 2026)
Onconetix (ONCO) posted quarterly Other Operating Expenses of $8.1 million for Q1 2026, down 25.5% year-over-year from $10.9 million in Q1 2025, and up 1269.36% quarter-over-quarter from $594000.0 in Q2 2025.
Onconetix (ONCO) Other Operating Expenses (2022 - 2026) Analysis & Trends
Onconetix (ONCO) has reported Other Operating Expenses for 5 consecutive years, with $8.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Operating Expenses fell 25.5% year-over-year to $8.1 million; the TTM figure through Mar 2026 stood at $8.7 million (down 82.4% YoY), while the FY2025 annual figure was $11.5 million, down 75.06% from the prior year.
- Other Operating Expenses advanced to $8.1 million in Q1 2026 per ONCO's latest filing, from $594000.0 in the prior quarter.
- Across five years, Other Operating Expenses topped out at $27.2 million in Q4 2024 and bottomed at $1615.0 in Q1 2023.
- Historically, Other Operating Expenses has averaged $7.0 million across 5 years, with a median of $5.5 million in 2023.
- Annual changes were most pronounced in 2024 — Other Operating Expenses jumped 463403.16% — and 2025, when it slumped 94.83%.
- Onconetix's Other Operating Expenses stood at $28035.0 in 2022, then jumped by 52289.32% to $14.7 million in 2023, then jumped by 85.02% to $27.2 million in 2024, then slumped by 97.81% to $594000.0 in 2025, then soared by 1269.36% to $8.1 million in 2026.
- Business Quant data shows ONCO's Other Operating Expenses at $8.1 million in Q1 2026, $594000.0 in Q2 2025, and $10.9 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Onconetix | 1.44 Mn | -4.50 Mn | 4,303.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 486,000.00 |
| Mar 31, 2026 | 8.13 Mn |
| Jun 30, 2025 | 594,000.00 |
| Mar 31, 2025 | 10.92 Mn |
| Dec 31, 2024 | 27.17 Mn |
| Jun 30, 2024 | 11.50 Mn |
| Mar 31, 2024 | 7.49 Mn |
| Dec 31, 2023 | 14.69 Mn |
| Jun 30, 2023 | 3.50 Mn |
| Mar 31, 2023 | 1,615.00 |
| Dec 31, 2022 | 28,035.00 |
| Sep 30, 2022 | 3,072.00 |
| Jun 30, 2022 | 30,303.00 |